We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
(-3.5%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$72.5M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$54.4M |
| 3 |
Blackstone
BX
|
+$44M |
| 4 |
Airbnb
ABNB
|
+$37.4M |
| 5 |
Everest Group
EG
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$57.8M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$39.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
| 4 |
iShares Global Infrastructure ETF
IGF
|
+$19.2M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.73% |
| 2 | Healthcare | 12.76% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Astec Industries
ASTE
$1.02B
| $3.48M | ﹤0.01% |
73,953
-1,749
| -2% | -$86.4K |
|
|
PMT
1552
PennyMac Mortgage Investment
PMT
$842M
| $3.48M | ﹤0.01% |
280,897
-4,999
| -2% | -$65.4K |
|
1553
Novartis
NVS
$297B
| $3.48M | ﹤0.01% |
34,183
+4,897
| +17% | +$497K |
|
1554
CVR Energy
CVI
$3.13B
| $3.48M | ﹤0.01% |
102,230
+653
| +0.6% | +$22.3K |
|
1555
Sterling Infrastructure
STRL
$16.7B
| $3.47M | ﹤0.01% |
47,250
+2,340
| +5% | +$164K |
|
|
AAT
1556
American Assets Trust
AAT
$1.4B
| $3.46M | ﹤0.01% |
178,054
-23,116
| -11% | -$486K |
|
1557
Green Brick Partners
GRBK
$3.14B
| $3.46M | ﹤0.01% |
83,373
-2,205
| -3% | -$110K |
|
1558
RingCentral
RNG
$5.28B
| $3.44M | ﹤0.01% |
116,178
-10,624
| -8% | -$353K |
|
1559
Sprout Social
SPT
$621M
| $3.44M | ﹤0.01% |
68,911
+2,412
| +4% | +$121K |
|
1560
Core Laboratories
CLB
$521M
| $3.44M | ﹤0.01% |
143,141
+3,703
| +3% | +$90.9K |
|
1561
Constellium
CSTM
$3.99B
| $3.43M | ﹤0.01% |
188,640
+6,779
| +4% | +$120K |
|
1562
Core & Main
CNM
$8.71B
| $3.43M | ﹤0.01% |
118,894
+21,047
| +22% | +$650K |
|
1563
Ligand Pharmaceuticals
LGND
$6.36B
| $3.42M | ﹤0.01% |
57,127
+1,628
| +3% | +$107K |
|
1564
Schneider National
SNDR
$6.25B
| $3.42M | ﹤0.01% |
123,600
-1,234
| -1% | -$35.9K |
|
1565
Nu Skin
NUS
$267M
| $3.42M | ﹤0.01% |
161,309
-646
| -0.4% | -$16.8K |
|
1566
Preferred Bank
PFBC
$1.25B
| $3.42M | ﹤0.01% |
54,921
+1,161
| +2% | +$72.5K |
|
|
CPRX
1567
DELISTED
Catalyst Pharmaceutical
CPRX
| $3.42M | ﹤0.01% |
292,186
+4,624
| +2% | +$61.9K |
|
1568
UFP Technologies
UFPT
$2.43B
| $3.39M | ﹤0.01% |
21,003
+338
| +2% | +$59.2K |
|
1569
ProPetro Holding
PUMP
$1.35B
| $3.39M | ﹤0.01% |
318,884
-16,160
| -5% | -$160K |
|
1570
Mueller Water Products
MWA
$4.16B
| $3.37M | ﹤0.01% |
266,027
-1,103
| -0.4% | -$15.9K |
|
1571
Buckle
BKE
$2.37B
| $3.37M | ﹤0.01% |
101,006
-868
| -0.9% | -$30.5K |
|
1572
Brookfield Renewable
BEPC
$6.26B
| $3.37M | ﹤0.01% |
140,725
+4,608
| +3% | +$134K |
|
1573
Clarivate
CLVT
$1.16B
| $3.37M | ﹤0.01% |
502,038
-58,589
| -10% | -$467K |
|
1574
Coursera
COUR
$1.54B
| $3.36M | ﹤0.01% |
179,997
+8,305
| +5% | +$132K |
|
1575
Apogee Enterprises
APOG
$908M
| $3.36M | ﹤0.01% |
71,448
-1,879
| -3% | -$91.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
- RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
- RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
- RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
- RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.
Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.